Involvement of mesosalpinx in endometrioma is a possible risk factor for decrease of ovarian reserve after cystectomy: a retrospective cohort study by unknown
RESEARCH Open Access
Involvement of mesosalpinx in
endometrioma is a possible risk factor for
decrease of ovarian reserve after
cystectomy: a retrospective cohort study
Ai Saito1, Akira Iwase1,2*, Tomoko Nakamura1, Satoko Osuka1,2, Bayasula1, Tomohiko Murase1, Nao Kato1,
Chiharu Ishida1, Sachiko Takikawa1, Maki Goto1 and Fumitaka Kikkawa1
Abstract
Background: Serum anti-Müllerian hormone (AMH) concentration has been used to assess ovarian reserve in
patients with endometriosis, especially when endometrioma surgery is involved. Previously, we reported that
decreased serum AMH levels after cystectomy for endometriomas can recover to preoperative levels in some cases.
In this present study, we assessed the sequential changes in serum AMH levels before and after cystectomy in
terms of the state of the mesosalpinx prior to surgery.
Methods: The retrospective cohort study recruited 53 patients from a series of prospective studies conducted from
2009 to 2015. All patients underwent laparoscopic cystectomy for endometriomas. If either mesosalpinx was
involved in the endometrioma or adnexal adhesion before cystectomy, the case was defined as ‘involved
mesosalpinx’ (n = 14). If both mesosalpinx remained anatomically correct, the case was classified as ‘intact
mesosalpinx’ (n = 39). Blood samples were obtained from the patients 2 weeks before surgery, and at 1 month and
1 year after surgery to assess serum AMH levels.
Results: The serum AMH levels (the involved group vs. the intact group) were 1.92 vs. 0.98 (P = 0.552)
preoperatively, 0.59 vs. 1.99 (P = 0.049) at 1 month postoperatively, and 0.48 vs. 2.37 ng/mL (P = 0.007) at 1 year
postoperatively. The involved mesosalpinx group showed a further decrease in serum AMH levels at 1 year
postoperatively, while serum AMH levels in the intact mesosalpinx group tended to recover.
Conclusion: These results suggest that pre-existing mesosalpinx disturbance, in combination with adhesiolysis, may
be involved in the medium- and long-term decrease in ovarian reserve after endometrioma surgery. A disturbance
in ovarian blood supply via the mesosalpinx may underlie this.
Trial registration: UMIN-CTR UMIN000019369. Retrospectively registered October 15, 2015.
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Background
Endometriosis, which is frequently seen in women of
reproductive age, is one of the most important causes of
infertility [1, 2]. Ovarian reserve is an indicator of ovarian
potential reflecting the number and quality of remaining
follicles [3]. It has been evaluated in association with
endometriosis and treatments for this condition [4–10].
Over the past decade, the serum anti-Müllerian hormone
(AMH) level has been widely used as a reliable quantita-
tive marker of ovarian reserve [11–14]. Since serum AMH
level is not dependent on the phases of the menstrual
cycle [15], measurement of serum AMH levels has
become part of routine clinical practice even outside of
infertility treatments. For example, it has been used to
evaluate ovarian damage resulting from surgery or chemo-
therapy [16, 17].
Laparoscopic cystectomy is the gold standard for man-
aging endometriomas. Evidence suggests that it results in a
lower recurrence rate and higher spontaneous pregnancy
rate than other types of treatment such as drainage and ab-
lation [18]. However, several studies have demonstrated the
decrease of ovarian reserve in terms of serum AMH levels
after laparoscopic cystectomy. The accidental loss of ovarian
cortex and the damage caused by electrocautery have been
proposed as possible causes for this decrease [8, 19, 20].
There is consensus that serum AMH levels decline
immediately after cystectomy for endometriomas [19].
However, the medium- and long-term effects of cystectomy
on ovarian reserve are still controversial. We have previ-
ously reported that the serum AMH levels at 1 year after
cystectomy can recover or decline further compared to the
AMH levels at 1 month after surgery [20]. Serum AMH
levels may recover if the environment surrounding the
ovary favors the growing follicle cohort, while less favorable
conditions may cause a further decline in ovarian reserve.
We speculate that the disturbance of blood supply to the
ovary is one such unfavorable condition.
The blood supply to the ovary is supported by the
ovarian ligament, suspensory ligament, and mesosalpinx.
Advanced endometriosis often involves these structures
and causes serious adhesions. One of the main aims of
surgery for endometriosis is to improve fertility by restor-
ing the normal anatomy of the reproductive organs; this
may be partly achieved by adhesiolysis. However, such
procedures risk affecting the blood supply to the ovary.
In this present study, we evaluated the anatomical
condition of the mesosalpinx in laparoscopic surgery for
endometriomas, and analyzed its relation to ovarian reserve
in terms of pre- and post-surgical serum AMH levels.
Methods
Patients
A series of prospective studies investigating serum AMH
levels in patients with endometriosis were conducted
from October 2009 to January 2015 in the Department
of Obstetrics and Gynecology of Nagoya University
Hospital in Nagoya, Japan. These studies were approved
by the ethical committee of Nagoya University Hospital,
and informed consent had been obtained from all pa-
tients prior to enrollment.
We recruited 53 patients as a retrospective cohort for
the current study. The inclusion criteria were as previ-
ously described [21]: 1) uni/bilateral endometrioma(s), 2)
women aged 20 to 42 years with regular menstrual cycles,
and 3) no evidence of any other endocrine disorders. The
exclusion criteria were as follows: 1) previous history of
adnexal surgery and 2) any findings suspicious of malig-
nant ovarian disease.
Surgery
All patients underwent laparoscopic surgery under general
anesthesia as previously described [21]. Adhesiolysis was
performed prior to ovarian cystectomy. The capsules of
the endometriomas were stripped from the healthy
surrounding ovarian tissue after the cleavage plane had
been identified. The use of bipolar forceps to achieve
hemostasis was minimized to avoid damage to normal tis-
sue. Sutures were used to close the ovarian parenchyma.
Endometriosis was classified according to the revised
American Society of Reproductive Medicine (rASRM)
classification system [22], and the diagnosis was confirmed
by histological examination of the excised specimens.
Evaluation and classification of mesosalpinx condition
The video recording of each surgery was thoroughly
inspected and analyzed by the same investigator (A.I.),
who was blinded to the patients’ identities. The investiga-
tor focused on the condition of the mesosalpinges before
surgery. If the mesosalpinx was affected by the endome-
trioma or involved in adnexal adhesion, the case was part
of the ‘involved mesosalpinx’ group. If both mesosalpinges
remained anatomically correct before and after surgery re-
gardless of the presence of endometriomas, the case was
classified into the ‘intact mesosalpinx’ group. Representa-
tive images of both groups are shown in Fig. 1.
AMH measurements
Blood samples were obtained from the patients 2 weeks
before surgery, and at 1 month and 1 year after surgery.
The serum was separated and stored as previously
described [20, 23]. The serum AMH concentrations were
measured with an enzyme immunoassay kit, AMH GenII
(Beckman Coulter, Inc., Brea, CA, USA). The intra-assay
and inter-assay variation coefficients were 5.4 % and 5.6 %
respectively. Samples with assay values under the AMH
Gen II detection limit were assayed using the picoAMH
(Ansh Labs, Webster, TX, USA) without dilution by the
same operator as described previously [23].
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Histologic analysis
To assess the removal of ovarian tissue, the pathological
slides were sliced out of paraffin blocks and selected at
equal distances. We counted the number of follicles,
including primordial, primary, secondary, and Graafian
follicles, from 4 or 5 slides selected according to the size
of the cyst wall. This was done using an optical micro-
scope (BX60; Olympus Corporation, Tokyo, Japan) as
previously described [20].
Antral follicle count
Antral follicle count (AFC) was measured by transvagi-
nal ultrasound (5-7.5 MHz transducer) 1 year after
surgery. AFC was defined as the total number of follicles
with a diameter less than 9 mm [24]. All ultrasound
examinations were performed by the same investigator.
Statistical analysis
All data were analyzed using the SigmaPlot13 software
program (Systat Software Inc., San Jose, CA). The stu-
dent’s t-test, Mann-Whitney U-test, and Fisher’s exact
test were used to compare the patient characteristics
and variables of interest between the intact mesosalpinx
and involved mesosalpinx groups. P < .05 was considered
statistically significant.
Results
A total of 53 patients were recruited, of whom 32 had uni-
lateral endometriomas and 21 had bilateral endometriomas.
They were classified into 2 groups, the ‘involved mesosal-
pinx’ group and the ‘intact mesosalpinx’ group, according to
the condition of their mesosalpinges as defined in the
materials and methods section. Table 1 shows their clinical
characteristics, including data on the operation and the
serum AMH levels. There were no statistically significant
differences in age, cyst size, blood loss during surgery,
number of follicles excised in specimens or preoperative
serum AMH levels between the groups. However, there
were significant differences in the ratio of unilateral/bilat-
eral cases and the rASRM score between the groups. In
addition, the serum AMH levels at 1 month and 1 year
after surgery were significantly lower in the involved group
compared to those in the intact group.
Figure 2 shows the sequential changes in the serum
AMH levels. Both groups had significant decreases in the
serum AMH levels at 1 month and 1 year after surgery
compared to the preoperative levels. However, the serum
AMH levels were unchanged at 1 year after surgery in the
intact group (Fig. 2a). The bilateral cases in the intact
group showed a slight recovery in serum AMH level at
1 year after surgery, while the bilateral cases in the
involved group showed a greater decrease at 1 year com-
pared to that at 1 month after surgery (Fig. 2b).
We then compared the AFC in the unilateral cases of
both groups. In the involved mesosalpinx group, we
found a large decrease in the AFC of the affected ovary
than in that of the control ovary. In the intact mesosal-
pinx group, the difference in AFC between the affected
ovary and control ovary was much smaller, albeit still
statistically significant (Table 2).
Discussion
In the current study, we demonstrated that mesosalpinx
disturbance, in tandem with adhesiolysis, has a larger
impact on the decline of AMH levels at 1 year after sur-
gery than at 1 month after surgery. Our results suggest
that serum AMH levels can recover if the follicle cohort
is restored, and that an adequate ovarian blood supply is
needed for this to take place.
Several clinical studies evaluating serum AMH levels
have suggested the importance of the ovarian blood supply
in determining ovarian reserve [25, 26]. Studies analyzing
Fig. 1 Involved mesosalpinx (a–c) and intact mesosalpinx (d–f) in endometrioma
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AMH levels in salpingectomy cases have provided useful
information with which our results can be discussed.
Cross-sectional studies have reported controversial results:
2 studies reported a decrease in serum AMH levels after
salpingectomy compared to that in cases that had not
undergone tubal surgery [27, 28]; on the contrary, Ni et al.
reported that tubal surgery improved the outcome of in
vitro fertilization without negatively impacting serum AMH
levels [29]. To our best of our knowledge, only 3 reports
comparing pre- and post-surgical AMH levels in fallopian
tube surgery have been published. Studies on tubal ligation
or tubal dissection did not find a significant decrease in
AMH levels [30, 31]. Venturella et al. reported a decline in
AMH levels after salpingectomy, although they noted that
the decrease of AMH levels between the usual salpin-
gectomy and “wide salpingectomy” with removal of
mesosalpinx groups were not significantly different [32].
However, the average age of the study participants exceeded
40 years, and the average preoperative AMH levels were
less than 1.0 ng/mL. This means that their results are less
applicable to females in their prime childbearing years, as
in our study.
There is a consensus that serum AMH levels decline
immediately after cystectomy for endometriomas [19].
However, studies on the medium- and long-term effects of
cystectomy on ovarian reserve show conflicting results.
Celik et al. assessed serum AMH levels preoperatively and
at 6 weeks and 6 months postoperatively. They reported
that AMH levels gradually decreased in patients with
bilateral tumors or those with cyst diameters ≥5 cm [5].
Ozaki et al. also reported that the reduced serum AMH
concentrations at 6 months after surgery were similar to
those at 3 months after surgery [33]. In our previous study,
we showed that both cases, increase and decrease of AMH
levels at one year after cystectomy, are comparative. On the
other hand, 2 studies reported that serum AMH levels at 6
Table 1 Patient characteristics
Characteristics and Variables Overall (n = 53) Involved mesosalpinx (n = 14) Intact mesosalpinx (n = 39) P value
Age [years] 34.1 ± 4.6 34.5 ± 5.1 34.0 ± 4.4 0.711a
Preoperative factors
Cyst size 1 [cm] 6.1 ± 2.0 5.5 ± 1.8 6.3 ± 2.1 0.203b
Cyst size 2 [cm] 3.3 ± 1.3 3.4 ± 1.0 3.2 ± 1.6 0.692a
Serum CA125 [IU/mL] 54.6 [30.4, 80.9] 49.6 [20.0, 79.8] 54.8 [32.6, 85.1] 0.246b
Surgery
Unilateral/Bilateral [n (%)] 32 (60) / 21 (40) 4 (29) / 10 (71) 28 (72) / 11 (28) 0.009c
Blood loss [mL] 55 [10, 260] 108 [8.8, 331] 50 [10, 159] 0.327b
rASRM score 36 [24, 75] 62 [39, 102] 28 [22, 64] 0.005b
Number of follicles in specimens 2.0 [0.0, 6.5] 2.0 [0.0, 6.3] 2.0 [0.0, 8.0] 0.992b
Serum AMH [ng/mL]
Preoperative 2.73 [1.49, 5.57] 1.92 [0.50, 6.92] 2.98 [1.63, 5.27] 0.552b
Postoperative 1 month 1.53 [0.49, 3.19] 0.59 [0.15, 2.40] 1.99 [0.75, 3.20] 0.049b
Postoperative 1 year 1.76 [0.47, 3.45] 0.48 [0.23, 2.10] 2.37 [0.76, 3.98] 0.007b
Note: Cyst size 1 represents the mean diameter of the unilateral cyst or the larger cyst in patients with bilateral cysts. Cyst size 2 represents the mean diameter of
the smaller cyst in patients with bilateral cysts. The values are presented as the mean ± SD or median [25th, 75th percentile]. P values in the unilateral vs. bilateral
groups. a,Student’s t-test. b,Mann-Whitney U test. c,Fisher's exact test
Fig. 2 The serial changes in the AMH levels before surgery, 1 month after surgery and 1 year after surgery in all cases (a) and in the bilateral
cases (b)
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or 12 months after surgery had recovered to preoperative
levels [34, 35]. This difference might be explained by the
preservation of the ovarian blood supply. In cases of
advanced endometriosis with severe adhesions, recovery of
serum AMH levels might prove difficult because of the
damage to the mesosalpinx caused by adhesiolysis.
Recently, several clinical studies measuring serum AMH
levels preoperatively and postoperatively have been con-
ducted to evaluate the methods used to achieve hemostasis.
Most of these studies compared suturing and bipolar coagu-
lation. Excessive bipolar coagulation causes damage to the
ovarian cortex, resulting in a postoperative decline in ovarian
reserve [36]. On the other hand, Shao et al. found a postop-
erative decline in serum AMH levels in the suturing group
after cystectomy [37]. The sutures might have been too tight,
which could have interrupted the ovarian blood supply. This
should be avoided in order to maintain ovarian reserve.
One limitation of our study was that the blood supply to
ovary was not assessed directly. The ovarian blood supply
is mediated by the ovarian ligaments, suspensory ligament
and mesosalpinx, and is extremely complex. Color Dop-
pler ultrasonography is useful for evaluating blood flow in
a wide range of organs and tissues; however, an optimal
method for assessing ovarian blood supply quantitatively
has yet to be established. Further studies should explore
this. This may help to improve our understanding of the
correlation between the postoperative changes in ovarian
blood supply and the decline of ovarian reserve.
We have previously reported that compared to pregnant
women, non-pregnant women had lower serum AMH levels
1 year after cystectomy for endometriomas [21]. This sug-
gested that a decrease in serum AMH levels 1 year after
cystectomy might negatively impact future fertility. As such,
we need to reconsider our surgical approach to endometri-
osis, such that the ovarian blood supply – mediated by ad-
nexal structures, especially the mesosalpinx – is maintained.
Conclusions
In conclusion, we demonstrated that the involvement of
mesosalpinx in endometrioma is a possible risk factor
for decrease of ovarian reserve after cystectomy. The
mesosalpinx disturbance, in tandem with adhesiolysis,
may have a negative impact on the ovarian blood supply.
Our results suggest that an adequate ovarian blood sup-
ply is required for the restoration of the follicle cohort
followed by recovery of serum AMH levels.
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